Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis in the Elderly: A Case-Controlled, Multicenter Study

Mohammad Alyami,P. Lundberg,Vahan Kepenekian,Diane Goéré,Jean-Marc Bereder,Simon Msika,G. Lorimier,F. Quenet,Gwenael Ferron,E. Thibaudeau,Karine Abboud,Rea Lo Dico,D. Delroeux,C. Brigand,Catherine Arvieux,Frédéric Marchal,Jean Jacques Tuech,Jean-Marc Guilloit,Frédéric Guyon,P. Peyrat,Denis Pezet,Pablo Ortega Deballon,F. Zinzindohoue,Cécile de Chaisemartin,Reza Kianmanesh,Olivier Glehen,Guillaume Passot

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis in the Elderly: A Case-Controlled, Multicenter Study

2016

Objective This study was designed to identify factors associated with morbidity and mortality in patients older than 70 years who underwent cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis (PC).

Keywords:

Hyperthermic intraperitoneal chemotherapy
General surgery
Peritoneal Cancer Index
Surgery
Pseudomyxoma peritonei
Medicine
peritoneal carcinomatosis
cytoreductive surgery
Cancer
Conventional PCI
Surgical oncology
Cohort

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations